At the human disease level, serum levels of interferon-controlled chemokines (e.g. CCL19 and CXCL10) have been found to correlate with current lupus activity, disease flare-up, and disease remission [33]. This evidence concerns the gene CXCL10 and systemic lupus erythematosus.